Navigation Links
Dennis R. Hill, MD to be a Panelist at the Third Annual Prostate Cancer Symposium Focusing on the Changing Paradigm of Prostate Cancer
Date:8/31/2013

Oakland, CA (PRWEB) August 31, 2013

Dennis R. Hill, MD has confirmed today that he will be a panelist at the Third Annual Prostate Cancer Symposium titled “The Changing Paradigm of Prostate Cancer: Selective screening, Personalized Treatment and Survivorship in a Period of Rapid Progress.” The event will be Tuesday, September 17 from 5:30 to 8:30pm and is sponsored by the Alta Bates Summit Health Education Center. At this year’s symposium an expert panel of physicians and professionals address the newest treatment options for prostate cancer, and how to pro-actively address quality of life and health issues during and after treatment. Discussions will cover screening, watchful waiting, treatment technology, nutrition, physical fitness as well as possible side effects like incontinence and urinary issues.

Dr. Hill’s presentation will be on High Dose Rate Brachytherapy for prostate cancer treatment vs Surveillance. Dr. Hill comments, “There is a changing paradigm in prostate cancer on several fronts, including screening, diagnosis and treatment. It can be confusing. Hopefully, this panel will not only bring the latest information out, but also some common sense on how to approach this important cancer.” The other physician panelists will present “Rational Approach to Screening and Treatment Decisions in the Era of Genetic Assessment” and “The Urologist’s Perspective on Surveillance vs Treatment” and “The March towards Controlling Recurrent and Aggressive Prostate Cancer.” There will also be panelist presentations on enhancing survivorship quality by a nutritionist and a physical therapist.

Following the presentations there will be a question and answer session with the panelists. The event is open to the public and will be held at Alta Bates Summit Health Education Center, 400 Hawthorne Avenue, Oakland, CA 94609. Reservations are required. To reserve a seat call (510) 204-5804 or send an email to slaveni(at)sutterhealth(dot)org.

About Dennis R. Hill MD

Dr. Hill has been doing High Dose Rate Brachytherapy for prostate cancer treatment exclusively since 2004 and has published scholarly articles on the subject. His office is located at: Dennis R. Hill MD 3012 Summit Street Suite 2675 Oakland, CA 94609 510-869-8875 drh(at)dennisrhillmd(dot)com and his website is hdrprostatebrachytherapy.com, which includes a quiz to determine if a patient is a candidate for HDR Prostate Brachytherapy.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11063124.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dennis R. Hill, MD to Speak at the American Cancer Society Man-to-Man Support Group to Discuss HDR Brachytherapy for Prostate Cancer Treatment
2. Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Discusses Prostate Cancer Stage vs. Gleason Score
3. Dennis R. Hill, MD to be a Panelist at the Third Annual Prostate Cancer Symposium Focusing on the Changing Paradigm of Prostate Cancer
4. Dennis R. Hill, MD to Speak at the American Cancer Society Man-to-Man Support Group to Discuss HDR Brachytherapy for Prostate Cancer Treatment
5. Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same
6. Althea Technologies Appoints Dr. Dennis Fenton As Chairman Of Its Scientific Advisory Board
7. Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors
8. Oramed CEO to be Panelist at BIO International Convention Breakout Session on Israel Becoming Biotech Leader
9. Amgen Announces 2013 Third Quarter Dividend
10. Aviir Secures Third $10 Million Financing Tranche To Fund Expanded Sales Of New Heart Risk Test
11. Case Western Reserve University, in Collaboration with NDI Medical, SPR Therapeutics and Valtronic Technologies, Receives $3 Million from Ohio Third Frontier Commission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Jan. 17, 2017   Pulmatrix, Inc . (NASDAQ: ... developing innovative inhaled therapies to address serious pulmonary diseases, ... infections in the lungs of CF patients, PUR1900, has ... by the U.S. Food & Drug Administration. ... to speed the development of novel drugs against important ...
(Date:1/17/2017)... , Jan. 17, 2017 Research ... report "Molecular Diagnostics - Technologies, Markets and Companies" ... ... diagnostics has increased remarkably during the past few years. More ... developing molecular diagnostics and 342 of these are profiled in ...
(Date:1/17/2017)... Jan. 17, 2017  Northwell Health today announced ... of precision cancer research. As ... health care provider, Northwell Health diagnoses and treats ... is a Germany -based oncology ... Together they will greatly expand cancer biobanking activities ...
(Date:1/17/2017)... ... January 17, 2017 , ... Pono Ola , a mind-body wellness firm ... today the official launch of its much-anticipated Pono Board: a re-invented fitness and anti-fatigue ... development for over a year, the patented Pono Board is the world’s only exercise ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
(Date:12/12/2016)... CLEVELAND , Dec. 12, 2016  Researchers ... commercial possibilities for graphene by combining the material ... a highly sensitive pressure detector able to sense ... of a small spider.  The ... and can be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/7/2016)... , Dec. 7, 2016   Avanade ... successful Formula One teams in history, exploit biometric data ... stop performance and maintain the competitive edge against their ... 2016. Avanade has worked with Williams ... range of biometric data (heart rate, breathing rate, temperature ...
Breaking Biology News(10 mins):